Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 262Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Fumaderm

02 8Tecfidera

PharmaCompass

01

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 3,841

2019 Revenue in Millions : 4,433

Growth (%) : -13

blank

02

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 1,444

2021 Revenue in Millions : 1,952

Growth (%) : -26

blank

03

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 1,013

2022 Revenue in Millions : 1,444

Growth (%) : -30

blank

04

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 2,909

2014 Revenue in Millions : 3,638

Growth (%) : 25%

blank

05

Brand Name : Fumaderm

Fumapharm AG

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Fumaderm

arrow
Fi Europe 2024
Not Confirmed

Fumapharm AG

Main Therapeutic Indication : Anti-fungal

Currency : USD

2015 Revenue in Millions : 63

2014 Revenue in Millions : 51

Growth (%) : -19%

blank

06

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 4,214

2016 Revenue in Millions : 3,968

Growth (%) : 6

blank

07

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 4,274

2017 Revenue in Millions : 4,214

Growth (%) : 1%

blank

08

Brand Name : Tecfidera

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Tecfidera

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 3,968

2015 Revenue in Millions : 3,638

Growth (%) : 9

blank

09

Brand Name : Fumaderm

Fumapharm Ag

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Fumaderm

arrow
Fi Europe 2024
Not Confirmed

Fumapharm Ag

Main Therapeutic Indication : Anti-Fungal

Currency : USD

2016 Revenue in Millions : 46

2015 Revenue in Millions : 51

Growth (%) : -10

blank

10

Brand Name : Fumaderm

Dimethyl Fumarate

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Fumaderm

arrow
Fi Europe 2024
Not Confirmed

Dimethyl Fumarate

Main Therapeutic Indication : Anti-fungal

Currency : USD

2017 Revenue in Millions : 40

2016 Revenue in Millions : 46

Growth (%) : -14

blank